0000950170-24-096419.txt : 20240813
0000950170-24-096419.hdr.sgml : 20240813
20240813170531
ACCESSION NUMBER: 0000950170-24-096419
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240809
FILED AS OF DATE: 20240813
DATE AS OF CHANGE: 20240813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glezer Eli N.
CENTRAL INDEX KEY: 0001859694
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40443
FILM NUMBER: 241202780
MAIL ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Singular Genomics Systems, Inc.
CENTRAL INDEX KEY: 0001850906
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 812948451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3010 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 333-7830
MAIL ADDRESS:
STREET 1: 3010 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-08-09
0001850906
Singular Genomics Systems, Inc.
OMIC
0001859694
Glezer Eli N.
3010 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
false
true
false
false
Chief Scientific Officer
false
Common Stock
2024-08-09
4
M
false
500
A
154083
D
Restricted Stock Units
2024-08-09
4
M
false
500
D
Common Stock
500
7000
D
Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs vest in 16 equal quarterly installments over four years measured from February 9, 2024.
/s/ Dalen Meeter, Attorney-in-Fact
2024-08-13